{
    "clinical_study": {
        "@rank": "50195", 
        "arm_group": [
            {
                "arm_group_label": "Ketamine-midazolam", 
                "arm_group_type": "Experimental", 
                "description": "300 to 500 mcg/kg ketamine plus 0.03 mg/kg midazolam"
            }, 
            {
                "arm_group_label": "Morphine", 
                "arm_group_type": "Active Comparator", 
                "description": "0.05 to 0.1 mg/kg morphine"
            }
        ], 
        "brief_summary": {
            "textblock": "the investigators assessed the effects of low-dose IV ketamine-midazolam versus morphine on\n      pain control in trauma patients with closed limb fracture(s); and also compared the\n      incidence of adverse events (mainly cardio pulmonary ) between two groups."
        }, 
        "brief_title": "Is Analgesic Effect of Low Dose Ketamine-midazolam the Same as Morphine", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Closed Multiple Fractures of Upper and Lower Limbs", 
        "condition_browse": {
            "mesh_term": "Fractures, Bone"
        }, 
        "detailed_description": {
            "textblock": "this prospective, single blind, noninferiority trial randomized consecutive ED patients aged\n      18 to 60 years to two groups: receiving either 300-500 mcg ketamine plus 0.03 mg midazolam,\n      or 0.05 to 0.1 mg morphine. Visual analogue score and adverse events were carefully verified\n      during an interval of 30 minutes.\n\n      Two hundreds, thirty six patients were selected, among whom were 207 males (87.3%), and 29\n      females (12.2%). The average age was 29\u00b12, with extremes of 60 years and 18 years.the\n      patients were divided into two groups: G1: 116 patients receiving ketamine-midazolam and G2:\n      120 patients receiving morphine alone."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Between 18 and 60 years\n\n          2. Patients with closed limb fracture(s)\n\n          3. VAS score of at least 6\n\n        Exclusion Criteria:\n\n          1. Acute pulmonary infection\n\n          2. Previous coronary artery diseases,ACS,congestive heart failure,\n\n          3. suspected aortic dissection\n\n          4. History of uncontrolled hypertention or blood pressure > 140/90mmHg\n\n          5. Brain injury with focal neurological deficit or loss of consciousness\n\n          6. Central nervous system mass lesion,hydrocephalus, or other states with increased\n             intracranial pressure\n\n          7. Glaucoma and acute globe injury\n\n          8. History of porphyria\n\n          9. Previous hyperthyroidism or thyroid hormone replacement\n\n         10. Pregnancy or laction\n\n         11. Major psychiatric disorder\n\n         12. Previous allergic reaction to the agents administered in the study\n\n         13. Patient declined to provide written informed conse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "236", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01807429", 
            "org_study_id": "390284"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ketamine-midazolam", 
                "description": "Ketamine 300-500mcg/kg plus midazolam 0.03 mg/kg once.", 
                "intervention_name": "Ketamine-midazolam", 
                "intervention_type": "Drug", 
                "other_name": "Ketaral"
            }, 
            {
                "arm_group_label": "Morphine", 
                "description": "morphine 0.05 mg/kg", 
                "intervention_name": "Morphine", 
                "intervention_type": "Drug", 
                "other_name": "Avinza"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ketamine", 
                "Morphine", 
                "Midazolam"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Ketamine,", 
            "Midazolam,", 
            "Morphine,", 
            "visual analogue score"
        ], 
        "lastchanged_date": "March 6, 2013", 
        "number_of_arms": "2", 
        "official_title": "Comparing Low Dose IV Ketamine-midazolam Versus IV Morphine Regarding ED Pain Control in Patients Sustaining Closed Limb Fracture(s)", 
        "other_outcome": {
            "description": "the patients were closely observed for any drug induced adverse events.", 
            "measure": "adverse drug effects", 
            "safety_issue": "Yes", 
            "time_frame": "30 minutes"
        }, 
        "overall_official": {
            "affiliation": "Isfahan University of Medical Sciences", 
            "last_name": "Omid Ahmadi, professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "the pain score was verified at the outset and every 10 minutes after administration of analgesics.", 
            "measure": "VAPS", 
            "safety_issue": "No", 
            "time_frame": "30 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01807429"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Isfahan University of Medical Sciences", 
            "investigator_full_name": "Mehdi Nasr Isfahani", 
            "investigator_title": "Mehdi Nasr Isfahani", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "the variables were assessed for an interval of 30 minutes.", 
            "measure": "HR,RR,SPO2,BP", 
            "safety_issue": "No", 
            "time_frame": "30 minutes"
        }, 
        "source": "Isfahan University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Isfahan University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}